April 24, 2024 by Business Roche’s Q1 results hit by loss of Covid sales, forex Roche has confirmed ambitions to return to sales growth this year on a continued boost from eye drug Vabysmo, after first-quarter sales slipped by 6% on the loss on Covid-19-related revenue. From our friends over at the : Business You can see the Full Story: Click Here